Lv7
4810 积分 2023-04-20 加入
Targeting IL-4/IL-13 Signaling Pathways in Chronic Rhinosinusitis with Nasal Polyps: From Mechanisms to Therapies
7个月前
已完结
Explainable artificial intelligence for predicting inflammatory signatures and spatial molecular heterogeneity from nasal polyp histology
8个月前
已完结
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
8个月前
已完结
Overall survival with camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy for recurrent or metastatic cervical cancer
8个月前
已完结
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
8个月前
已完结
WAYPOINT: Are we there yet for patients with nasal polyposis?
8个月前
已完结
WAYPOINT: Are we there yet for patients with nasal polyposis?
8个月前
已关闭
WAYPOINT: Are we there yet for patients with nasal polyposis?
8个月前
已关闭
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
8个月前
已完结
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
8个月前
已关闭
皖公网安备34019202002308
